Publicacións en colaboración con investigadores/as de Hospital de Cruces (17)

2024

  1. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

    npj Parkinson's Disease, Vol. 10, Núm. 1

2023

  1. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease

    Journal of Neurology, Vol. 270, Núm. 8, pp. 3821-3829

2022

  1. Spatial characterization of the effect of age and sex on macular layer thicknesses and foveal pit morphology

    PLoS ONE, Vol. 17, Núm. 12 December

2021

  1. A global analysis of the reconstitution of PTEN function by translational readthrough of PTEN pathogenic premature termination codons

    Human Mutation, Vol. 42, Núm. 5, pp. 551-566

  2. Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease

    PLoS ONE, Vol. 16, Núm. 12 December

  3. Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease

    Frontiers in Neuroscience, Vol. 15

  4. Foveal pit morphology characterization: A quantitative analysis of the key methodological steps

    Entropy, Vol. 23, Núm. 6

  5. Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease

    Annals of Neurology, Vol. 89, Núm. 1, pp. 165-176

2019

  1. Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma

    Diagnostic Pathology, Vol. 14, Núm. 1

2018

  1. DUSP5 expression associates with poor prognosis in human neuroblastoma

    Experimental and Molecular Pathology, Vol. 105, Núm. 3, pp. 272-278

  2. Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution

    Virchows Archiv, Vol. 472, Núm. 2, pp. 187-194

2017

  1. Building Bridges through Science

    Neuron

  2. CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma

    APMIS, Vol. 125, Núm. 2, pp. 128-133

2016

  1. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma

    Human Pathology, Vol. 54, pp. 100-105

  2. Snail heterogeneity in clear cell renal cell carcinoma

    BMC Cancer, Vol. 16, Núm. 1

2015

  1. Information Flow between Resting-State Networks

    Brain Connectivity, Vol. 5, Núm. 9, pp. 554-564

  2. Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous

    Virchows Archiv, Vol. 466, Núm. 1, pp. 61-66